Aktuelle Veröffentlichungen

Susann Triemer, Kerry Gilmore, Giang T. Vu, Peter H. Seeberger, Andreas Seidel-Morgenstern
Angewandte Chemie International Edition, 21. Februar 2018
DOI: 10.1002/anie.201801424

Björn-Johannes Harder, Katja Bettenbrock, Steffen Klamt
Temperature-dependent dynamic control of the TCA cycle increases volumetric productivity of itaconic acid production by Escherichia coli.
Biotechnology and Bioengineering, Volume 115, Ausgabe 1, Seiten 156–164, Januar 2018, DOI: 10.1002/bit.26446
Open Access Artikel

Lihong Feng, Athanasios C. Antoulas und Peter Benner
Some a posteriori error bounds for reduced-order modelling of (non-)parametrized linear systems
ESAIM: Mathematical Modelling and Numerical Analysis, Volume 51, Number 6, 27. November 2017
DOI: 10.1051/m2an/2017014

Lado Otrin, Nika Marušič, Claudia Bednarz, Tanja Vidaković-Koch, Ingo Lieberwirth, Katharina Landfester und Kai Sundmacher
Toward Artificial Mitochondrion: Mimicking Oxidative Phosphorylation in Polymer and Hybrid Membranes
Nano Letters, 17 (11), pp 6816–6821, 25. Oktober 2017
DOI: 10.1021/acs.nanolett.7b03093

Eileen Edler und Matthias Stein
Recognition and stabilization of geranylgeranylated human Rab5 by the GDP Dissociation Inhibitor (GDI)
SmallGTPases, pp. 1-16, 25. Oktober 2017
DOI: 10.1080/21541248.2017.1371268
Open Access Artikel

Marian Weiss, Johannes Patrick Frohnmayer, Lucia Theresa Benk, Barbara Haller, Jan-Willi Janiesch, Thomas Heitkamp, Michael Börsch, Rafael B. Lira, Rumiana Dimova, Reinhard Lipowsky, Eberhard Bodenschatz, Jean-Christophe Baret, Tanja Vidakovic-Koch, Kai Sundmacher, Ilia Platzman, Joachim P. Spatz
Sequential bottom-up assembly of mechanically stabilized synthetic cells by microfluidics
Nature Materials, 16. Oktober 2017
DOI: 10.1038/nmat5005

Zu ausgewählten Publikationen ...

Veranstaltungen

Willkommen am Max-Planck-Institut Magdeburg

Nachrichten

Vortrag im Rahmen der Hybrid Modeling Summer School

2413 1441723591

Synthetic Biology and delivering on, From Gene to Product

Abstract: To some people we may be entering the period of the ‘Fourth Industrial Revolution’ - the Biological Industrial Revolution. Just as in previous industrial revolutions the potential previously promised by coal, mechanisation and electronics has now to be realised by the exploitation of biological potential. This new potential is made available by large scale gene synthesis and expression and understanding the options available for the scale-up and control of novel genetic entities. It seems that in order to start to understand fully how the exploitation of novel biological potential may be realised there needs to be a recognition of the scale and complexity of the task. Novel methodologies in numerical analysis and experimental design as well as in automation and bioprocess engineering need to be employed and coordinated in order to gain commercial traction on synthetic biology. This short talk will seek to identify how techniques of large scale experimental design, scale up and analyses, as well as a novel approach to biological automation are seeking to address just some of the issues surrounding Synthetic Biology and delivering on ‘From Gene to Product’. Short biography of Mr. Craig JL Gershater: Craig is a senior scientist and manager with over 40 years’ industrial bioprocess optimisation and biotechnology experience. He has held a variety of senior positions in the pharmaceutical industry, lastly as Head of Fermentation Sciences R&D at SmithKline Beecham prior to becoming the CEO and Principal Consultant with Cambridge Bioprocess Management Ltd in 2000. Among his many transnational clients in recent years he has worked with GSK, as well as a number of SMEs and in academia. He is an expert in the application of statistical methods to experimental design and rapid bioprocess optimisation. He has used these techniques in a wide variety of industrial research and development projects including full scale development of biotechnology projects to GMP/GLP requirements. [mehr]

 
Zur Redakteursansicht
loading content